方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 皮肤病学生活质量指数× | EORTC QLQ-C30：癌症生活质量评估的核心问卷× | |
|---|---|---|
| 领域 | 健康结局 | 健康结局 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1994 | 1993 |
| 提出者≠ | Andrew Y. Finlay and Gul K. Khan | Nico Aaronson et al. |
| 类型 | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| 开创性文献≠ | Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19(3), 210-216. DOI ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| 别名 | DLQI, Finlay Index, Dermatology Quality of Life | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| 相关≠ | 3 | 5 |
| 摘要≠ | The DLQI is the primary patient-centered outcome measure in dermatology research and clinical practice. Developed by Andrew Finlay and Gul Khan in 1994, this 10-item self-report questionnaire quantifies the impact of skin disease on patients' daily functioning, emotional well-being, social relationships, and work capacity. It is simple, rapid, and applicable to virtually all dermatological conditions, making it the gold standard for assessing quality of life in dermatology. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGate数据集 ↗ |
|
|